Multiple cross displacement amplification (MCDA) for rapid detection of toxigenic Clostridioides difficile as a potential point-of-care testing
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.03030-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Hui Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Laboratory Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, Ch…. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections, Point-of-Care Testing, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program for Major Science and Technology Medicine and Healthcare in Zhejiang, Medical Scientific Research Foundation of Zhejiang Province, China, Scientific Research Fund of Zhejiang Provincial Education Department.
Abstract (Originalsprache)
Toxigenic Clostridioides difficile is the cause of C. difficile infection, highlighting the critical need for rapid and easy-to-use detection. In this study, a multiple cross displacement amplification (MCDA) assay was developed to detect toxigenic C. difficile and evaluated against real-time PCR and VIDAS C. difficile toxin A & B assay (CDAB). The results showed that MCDA targeting the C. difficile tcdB gene had a limit of detection (LOD) of 12.5 fg (2.5 copies of genomic DNA) per reaction with no non-specific amplification from other pathogens. The LOD for MCDA was the same as real-time PCR but had significantly faster detection time, detecting 500 pg and 12.5 fg per reaction in 5.7 ± 0.5 and 21.35 ± 2.2 min, respectively. Among 201 stool samples, MCDA identified 40 positive for toxigenic C. difficile with a shorter average detection time of 16.08 ± 4.62 min compared to real-time PCR (39.82 ± 4.44 min). Using cell cytotoxicity neutralization assays as reference, MCDA demonstrated a significantly higher specificity (92.4%) and a positive predictive value (67.5%) than real-time PCR (80.8 and 43.2%, respectively; P < 0.05). MCDA also had a significantly higher sensitivity (93.1%) and a negative predictive value (98.8%) compared to VIDAS CDAB (34.5 and 90.1%, respectively; P ≤ 0.001). This was also higher compared to real-time PCR (86.2 and 97.2%, P > 0.05). MCDA offers a promising screening alternative for point-of-care testing to detect toxigenic C. difficile and effectively rule out non-toxigenic C. difficile . It is rapid, easy to use, and has a balanced performance, making it applicable in clinical and community settings, particularly in resource-limited settings. IMPORTANCE Rapid detection of toxigenic Clostridioides difficile is important for early intervention and outbreak control of C. difficile infection in primary healthcare facilities. This study developed an MCDA assay and showed that it was rapid, sensitive, user-friendly, and a suitable point-of-care screening alternative for accurately detecting toxigenic C. difficile . MCDA had the same sensitivity as real-time PCR while providing significantly faster turnaround times and improved specificity along with positive and negative predictive values. Its balanced performance and rapid detection capability make it well-suited for clinical detection of toxigenic C. difficile and point-of-care testing in communities, particularly in resource-limited settings, and for potential self-testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Laboratory Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
- Key Laboratory of Biomarkers and In Vitro Diagnosis Translation of Zhejiang Province, Hangzhou, Zhejiang, China.
- School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
- Diago Biotech Pty Ltd, Sydney, New South Wales, Australia.
Förderung
- Program for Major Science and Technology Medicine and Healthcare in Zhejiang
- Medical Scientific Research Foundation of Zhejiang Province, China
- Scientific Research Fund of Zhejiang Provincial Education Department
Zitieren
APA
Hu, H., Zhang, X., Cai, M., Song, X., Cheng, H., Zhai, F., Tai, Y., Xu, Z., Lin, S., Chen, Y., Luo, Y., & Jin, D. (2025). Multiple cross displacement amplification (MCDA) for rapid detection of toxigenic Clostridioides difficile as a potential point-of-care testing. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03030-24
Vancouver
Hu H, Zhang X, Cai M, Song X, Cheng H, Zhai F, et al. Multiple cross displacement amplification (MCDA) for rapid detection of toxigenic Clostridioides difficile as a potential point-of-care testing. Microbiology Spectrum. 2025. doi:10.1128/spectrum.03030-24
BibTeX
@article{Hu2025,
author = {Hu, Hui and Zhang, Xiaomei and Cai, Mengting and Song, Xiaojun and Cheng, Hongrui and Zhai, Fangya and Tai, Yulei and Xu, Zheng and Lin, Shan and Chen, Yu and Luo, Yun and Jin, Dazhi},
title = {Multiple cross displacement amplification (MCDA) for rapid detection of toxigenic Clostridioides difficile as a potential point-of-care testing},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.03030-24}
}
EUVIMED